Motus GI Holdings with ticker code (MOTS) now have 6 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The target price ranges between 3 and 2 with a mean TP of 2.5. With the stocks previous close at 0.97 this indicates there is a potential upside of 157.7%. There is a 50 day moving average of 0.9 and the 200 moving average now moves to 1.05. The company has a market capitalisation of $32m. Find out more information at: http://www.motusgi.com
Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.